issued
on 10 Dec 2024
Last Applicant/ Owned by
180 3rd Avenue, Fifth Floor
Waltham
MA
02451
Serial Number
98412294 filed on 20th Feb 2024
Registration Number
N/A
Correspondent Address
Peter Kunin
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression, used in the treatment of cancers, cardiovascular diseases, immunological diseases, autoimmune diseases, neuromuscular diseases, blood disorders, rare genetic disorders, fibrosis; pharmaceuticals used in the treatment of cancers, cardiovascular diseases, immunological diseases, autoimmune diseases Read More
Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression, used in the treatment of cancers, cardiovascular diseases, immunological diseases, autoimmune diseases, neuromuscular diseases, blood disorders, rare genetic disorders, fibrosis; pharmaceuticals used in the treatment of cancers, cardiovascular diseases, immunological diseases, autoimmune diseases, neuromuscular diseases, blood disorders, rare genetic disorders, fibrosis
N/A
N/A
No 98412294
No Service/Collective Mark
No 16694006UST3
No
No
No
No
No
No
No
No
24.15.04 -
Arrowheads
26.05.21 -
Triangles that are completely or partially shaded
Status Date | Action Taken |
---|---|
10th Dec 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
29th Oct 2024 | PUBLISHED FOR OPPOSITION |
29th Oct 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
09th Oct 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
23rd Sep 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
22nd Sep 2024 | EXAMINERS AMENDMENT E-MAILED |
22nd Sep 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
22nd Sep 2024 | EXAMINERS AMENDMENT -WRITTEN |
22nd Sep 2024 | EXAMINER'S AMENDMENT ENTERED |
22nd Aug 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |